comparemela.com

Latest Breaking News On - ஆரக்கிள் ஆரோக்கியம் அறிவியல் இணைக்கவும் - Page 1 : comparemela.com

Are decentralized trials fast becoming the new norm?

As COVID-19 response initiatives and vaccine rollouts begin to bring the pandemic under control, we consider what changes to clinical trials will be made permanent. Top of mind for Rob Church, a pharmaceutical and biotechnology regulatory law expert at US firm, Hogan Lovells, is the future of clinical studies, particularly in light of the decentralized clinical trial (DCT) trend seen over the past year. The pandemic has been the catalyst in speeding up the wider adoption of DCTs, with sponsors using electronic remote informed consent, remote outcomes assessments, and, in some cases, remote administration of a study drug, and home health visits by clinical study staff, he told us

Avance Clinical to Present Decentralized Trials - No Going Back for Oracle Health Sciences Connect

Avance Clinical to Present Decentralized Trials - No Going Back for Oracle Health Sciences Connect The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Avance Clinical CEO Yvonne Lungershausen, shared the company s insights on the future of Decentralized Clinical Trials (DCTs) and the technology and patient factors that will determine success. Avance Clinical uses the full range of eClincial technologies to support clients wanting DCTs or a site-based approach while still leveraging advance technology including ePro, eSource and eConsent.

Avance Clinical Invited to Present Decentralized Trials - No Going Back for Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Title: Decentralized Trials - No Going Back Link: https://www.oracle.com/in/industries/life-sciences/health-sciences-connect/sessions/ Time: 23 April, 2021 - 3.05 pm (Australia/Adelaide ACST). Avance Clinical CEO Yvonne Lungershausen, shared the company s insights on the future of Decentralized Clinical Trials (DCTs) and the technology and patient factors that will determine success. Avance Clinical uses the full range of eClincial technologies to support clients wanting DCTs or a site-based approach while still leveraging advance technology including ePro, eSource and eConsent.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.